NervGen Pharma Corp. (NGEN.V)
6.02
+0.17
(+2.91%)
CAD |
TSXV |
Feb 20, 16:00
NervGen Pharma EPS Diluted (Quarterly) : -0.0568 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arch Biopartners, Inc. | -0.0041 |
| Biocure Technology, Inc. | -0.0029 |
| Resverlogix Corp. | -0.0046 |
| Microbix Biosystems, Inc. | -0.0084 |
| Theratechnologies, Inc. | -0.1271 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.156M |
| Total Expenses (Quarterly) | 4.156M |
| Enterprise Value | 460.27M |
| Earnings Yield | -6.01% |
| Normalized Earnings Yield | -5.867 |